Imperative Care announced today that it appointed Chuck Alpuche as its new COO along with a slew of leadership changes. The stroke care company named Peter Griffin as SVP of operations, Scott Elliott as chief legal officer and Daniel Davis as chief strategy officer, too. Fred Khosravi, Imperative Care CEO and chair, said the moves […]
Vascular
Surmodics has positive early results from thrombectomy system
Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce LP thrombectomy system. Eden Prairie, Minnesota-based Surmodics designed the LP (low-profile) thrombectomy system for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature. It performs this removal in vessels between 3.5 mm and 6 mm in diameter. It introduced the […]
Gore enrolls first patients in expandable stent graft trial
W.L. Gore & Associates announced today that it enrolled the first patients in a trial evaluating its Viabahn VBX stent graft. The study compares Gore’s balloon-expandable endoprosthesis to bare metal stenting for patients with complex iliac occlusive disease. It aims to inform practice guidelines around the best modalities suited for patients with this condition. Dr. […]
Autonomix completes preclinical transvascular ablation study to treat pancreatic cancer
Autonomix Medical announced today that it completed an animal safety study evaluating its proprietary ablation technology. The Woodlands, Texas-based company designed its tissue ablation technology to address pancreatic cancer-related pain. Current approaches, like opioids or ethanol injections, may only provide limited relief and may lead to risky side effects. The company hopes its proof-of-concept effort […]
Shockwave Medical plans for growth with 2-3 product launches each year
It was a busy 2023 for Shockwave Medical (Nasdaq:SWAV), with product launches, funding rounds and M&A at the heart of it. The company, which develops intravascular lithotripsy (IVL) technology, first made waves last year with its acquisition of Neovasc. Neovasc develops the Reducer system for addressing refractory angina. Shockwave remained in the middle of M&A […]
LivaNova to wind down advanced circulatory support unit, focus on cardiopulmonary, neuromod
LivaNova announced today that it intends to begin winding down its advanced circulatory support (ACS) business unit. The orderly wind-down is part of an effort to focus on the company’s core cardiopulmonary (CP) and neuromodulation units. ACS generated approximately just 4% of LivaNova’s net revenue for the nine months ended Sept. 30, 2023. The company […]
FDA clears neurovascular aspiration, access catheters from Perfuze
Perfuze announced today that the FDA cleared its Millipede 070 aspiration catheter and second-generation Millipede 088 access catheter. Galway, Ireland-based Perfuze developed Millipede 070 to address critical unmet needs in ischemic stroke treatment. It aims to remove clots rapidly and safely through a novel, unique catheter. Millipede 070 has a unique design with a rib-and-recess […]
Ablative Solutions hits primary endpoint in renal denervation for hypertension trial
Ablative Solutions announced today that its TARGET BP I pivotal trial evaluating its Peregrine System kit met its primary endpoint. The trial evaluates alcohol-mediated renal denervation to treat hypertension with the Peregrine System. Wakefield, Massachusetts-based Ablative Solutions reported a statistically significant difference in 24-hour ambulatory blood pressure between treatment and sham procedure at three months. […]
Imperative Care begins first-in-human study of neurovascular stent
Imperative Care announced today that it initiated a first-in-human clinical study for its novel neurovascular stent system. Campbell, California-based Imperative Care designed the system to only require single antiplatelet therapy for patients undergoing stent-assisted treatment of wide-neck intracranial aneurysms. Dr. Nobuyuki Sakai successfully treated the first three patients enrolled in the study. Sakai serves as […]
Vivasure treats first patients with percutaneous vessel closure device
Vivasure Medical announced today that the first patient received treatment with its PerQseal Elite large-hole closure system. Galway, Ireland-based Vivasure designed the latest-generation PerQseal Elite for percutaneous vessel closure. It leverages the legacy platform’s safety profile and ease of use while allowing for faster delivery. The new system also improves performance in calcium and the […]
Pulmonary embolism startup Flow Medical raises $2M in friends-and-family round
Flow Medical announced today that it has raised $2 million in a friends-and-family funding round. Chicago-based Flow Medical is developing a new thrombolysis catheter for treating acute pulmonary embolism (PE). The startup said it will use the funding for R&D and regulatory activities. Flow Medical is led by co-founder and CEO Jennifer Fried, the co-founder […]